Centre Oscar Lambret

Futó vizsgálatok

• Toboroz

  Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department

  NCT07202507· Forrás

• Még nem toboroz

  Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer

  NCT06726330· Forrás

• Még nem toboroz

  Bacterial Decolonization to Prevent Severe Radiation Dermatitis in Head and Neck Squamous Cell Carcinoma

  NCT07888907· Forrás

• Még nem toboroz

  Analysis of histological risk factors and biomarkers in paediatric retinoblastoma

  2024-515962-15-00· 2. fázis· Forrás

• Még nem toboroz

  Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas

  NCT07924384· Forrás

• Még nem toboroz

  Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer

  NCT07759492· 2. fázis· Forrás

• Még nem toboroz

  Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)

  NCT07782112· 3. fázis· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· 3. fázis· Forrás

• Még nem toboroz

  Impact of Probiotics on Neuropathy Induced by Adjuvant Chemotherapy in Patients With Colon Cancer.

  NCT07733817· Forrás

• Még nem toboroz

  Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer

  NCT07490106· Forrás

• Még nem toboroz

  Phase I/II trial of Dinutuximab beta in combination with Irinotecan and Rapamycin in pediatric, adolescents and adult patients with relapsed/refractory bone tumors. BONE DINIRRA

  2026-525463-40-00· 1/2. fázis· Forrás

• Még nem toboroz

  Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.

  NCT07717450· 3. fázis· Forrás

• Toboroz

  A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

  NCT07701941· 1/2. fázis· Forrás

• Toboroz

  Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

  NCT07473128· 3. fázis· Forrás

• Még nem toboroz

  Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer

  NCT07151586· 2. fázis· Forrás

• Még nem toboroz

  SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer

  NCT07241273· Forrás

• Még nem toboroz

  Reduction of treatment after Complete Response in Advanced Hormone-Sensitive Breast Cancer

  2026-526319-12-00· 3. fázis· Forrás

• Még nem toboroz

  Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases

  NCT07359456· 2. fázis· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)

  2023-505575-69-01· 3. fázis· Forrás

• Toboroz

  Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall

  NCT07507773· 2. fázis· Forrás

• Toboroz

  Phase II study of ficerafusp alfa in combination with nivolumab in patients with platinum-refractory head and neck squamous cell carcinoma who progressed within 6 months of multimodality therapy for locally advanced disease.

  2025-521437-88-00· 2. fázis· Forrás

• Toboroz

  Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  NCT07566156· 3. fázis· Forrás

• Toboroz

  Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

  NCT07264075· 3. fázis· Forrás

• Toboroz

  MATRIX-IPC 2022-029 A phase I/II study evaluating Tuvusertib (M1774), an ATR Inhibitor, in combination with fulvestrant in hormone receptors-positive and HER2-negative, advanced breast cancers, resistant to CDK4/6 inhibitor plus aromatase inhibitor-based endocrine treatment and with homologous recombination deficiency, oncogenic driver activation and/or other molecular alterations associated with replication stress (RS)

  NCT05986071· 1/2. fázis· Forrás

• Toboroz

  A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

  NCT07405801· 2. fázis· Forrás

• Még nem toboroz

  Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)

  NCT07337447· 2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  NCT07293351· 1/2. fázis· Forrás

• Toboroz

  A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

  NCT07491497· 1/2. fázis· Forrás

• Toboroz

  Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11)

  NCT07043543· Forrás

• Toboroz

  Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management

  NCT07371585· 2. fázis· Forrás

• Toboroz

  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  NCT07318558· 3. fázis· Forrás

• Toboroz

  Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)

  NCT06937905· 3. fázis· Forrás

• Toboroz

  A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

  NCT07219212· 1. fázis· Forrás

• Toboroz

  TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

  NCT07190300· 1/2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· 2/3. fázis· Forrás

• Toboroz

  A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT07225946· 3. fázis· Forrás

• Toboroz

  To compare the Safety and activity of GDC-4198 Alone and in Combination with Giredestrant against Abemaciclib and Giredestrant in Participants with Breast Cancer

  2025-521128-31-00· 1/2. fázis· Forrás

• Toboroz

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· 3. fázis· Forrás

• Toboroz

  A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

  NCT07244341· 1. fázis· Forrás

• Toboroz

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· 3. fázis· Forrás

• Toboroz

  Phase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  2025-520555-89-00· 3. fázis· Forrás

• Toboroz

  Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

  NCT06656598· 2. fázis· Forrás

• Toboroz

  Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors

  NCT07243470· 1/2. fázis· Forrás

• Toboroz

  Testing ivonescimab in combination with standard chemotherapy in advanced or metastatic gastric and gastroesophageal adenocarcinoma patients

  NCT06846346· 2. fázis· Forrás

• Toboroz

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· 3. fázis· Forrás

• Toboroz

  Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention

  NCT06599879· Forrás

• Toboroz

  Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.

  NCT07195344· 4. fázis· Forrás

• Toboroz

  Influence des caractéristiques morphologiques sur la pharmacocinétique et la toxicité du trastuzumab-déruxtécan chez des patients ayant un cancer du sein métastatique (TDXdose)

  2025-522656-68-00· 4. fázis· Forrás

• Toboroz

  Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck

  NCT06959108· 2. fázis· Forrás

• Toboroz

  Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

  NCT06529718· 2. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok34 toboroz
• Áttétes emlőrák22 toboroz
• Petefészekrák20 toboroz
• Prosztatarák19 toboroz
• Szarkóma19 toboroz
• Fej-nyaki daganatok16 toboroz
• Tüdőrák13 toboroz
• Vastagbélrák9 toboroz
• Vesedaganat8 toboroz
• Hólyagrák7 toboroz
• Hasnyálmirigyrák6 toboroz
• Máj- és epeúti rák6 toboroz
• Neuroendokrin daganatok6 toboroz
• Gyomor- és nyelőcsőrák5 toboroz
• Méhtestrák5 toboroz
• Neuroblasztóma5 toboroz
• Tripla negatív emlőrák5 toboroz
• Méhnyakrák3 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Glioblasztóma1 toboroz
• Melanóma1 toboroz
• Mezotelióma1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab

  NCT07061080· 2. fázis· Forrás

• Toboroz

  Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)

  2024-517819-74-00· 1/2. fázis· Forrás

• Lezárult

  Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

  NCT06433219· 2. fázis· Forrás

• Visszavonták

  Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures

  NCT06084689· 2. fázis· Forrás

• Lezárult

  Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

  NCT06119217· 2. fázis· Forrás

• Leállították

  Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer

  NCT06181201· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

  NCT06105632· 2. fázis· Forrás

• Lezárult

  A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma.

  NCT04718675· 1. fázis· Forrás

• Lezárult

  Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma

  NCT05821231· 1. fázis· Forrás

• Lezárult

  Randomized, non-comparative, open-label early phase Ib study with OBT076 or OBT076 followed by Balstilimab in patients with Adenoid Cystic Carninoma of the Head and Neck

  2023-503270-20-00· 1. fázis· Forrás

• Lezárult

  Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck cancer

  NCT05724602· 2. fázis· Forrás

• Lezárult

  A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer

  NCT05846594· Forrás

• Lezárult

  A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

  NCT03966651· 1. fázis· Forrás

• Lezárult

  A Phase 1 Study of the SHP2 Inhibitor BBP-398 (formerly known as IACS-15509) in combination with the KRAS-G12C Inhibitor Sotorasib in Patients with Advanced Solid Tumors and a KRAS-G12C Mutation

  NCT05480865· 1. fázis· Forrás

• Lezárult

  OMX-0407 Phase I Study

  NCT05826600· 1. fázis· Forrás

• Lezárult

  Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION)

  2023-508528-36-00· 3. fázis· Forrás

• Leállították

  A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05325866· 1/2. fázis· Forrás

• Fut, nem toboroz

  Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

  NCT05257408· 3. fázis· Forrás

• Lezárult

  A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

  NCT05323656· 2. fázis· Forrás

• Lezárult

  Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT05218499· 2/3. fázis· Forrás

• Lezárult

  Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumours

  2024-511071-16-00· 1. fázis· Forrás

• Lezárult

  A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

  NCT05198804· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

  NCT05143970· 1. fázis· Forrás

• Lezárult

  Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG

  NCT04934865· Forrás

• Lezárult

  Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC

  NCT04725396· Forrás

• Lezárult

  Impact of Personalized and Remote Support Centered on Exercise and Physical Activity for Breast Cancer Patients

  NCT04536584· Forrás

• Leállították

  Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer

  NCT04450836· 2. fázis· Forrás

• Lezárult

  Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations

  NCT04357873· 2. fázis· Forrás

• Leállították

  A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

  NCT04459715· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

  NCT04300556· 1/2. fázis· Forrás

• Leállították

  A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

  NCT04338269· 3. fázis· Forrás

• Leállították

  Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer

  NCT04016142· 2. fázis· Forrás

• Toboroz

  Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

  NCT04428554· 2. fázis· Forrás

• Lezárult

  Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)

  2023-509542-35-00· 1. fázis· Forrás

• Lezárult

  MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

  NCT04216953· 1/2. fázis· Forrás

• Lezárult

  A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

  NCT04083235· 3. fázis· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

  NCT04191499· 2/3. fázis· Forrás

• Lezárult

  Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours

  NCT04236414· 1. fázis· Forrás

• Lezárult

  Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

  NCT04168788· Forrás

• Lezárult

  A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

  NCT04209855· 3. fázis· Forrás

• Lezárult

  Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

  NCT03948724· Forrás

• Lezárult

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· 2. fázis· Forrás

• Lezárult

  Study of DF1001 in Patients With Advanced Solid Tumors

  NCT04143711· 1/2. fázis· Forrás

• Lezárult

  Molecular Profiling of Advanced Soft-tissue Sarcomas

  NCT03784014· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

  NCT04008030· 3. fázis· Forrás

• Lezárult

  Trial evaluating the tolerance and safety of durvalumab - radiotherapy combination for treatment of cancers of the head and neck

  2024-513977-31-00· 2. fázis· Forrás

• Lezárult

  Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma

  NCT04267146· 1/2. fázis· Forrás

• Lezárult

  Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer

  NCT03879109· 3. fázis· Forrás

• Leállították

  Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer

  NCT03922776· Forrás

• Lezárult

  Phase II Study of Regorafenib as Maintenance Therapy

  NCT03793361· 2. fázis· Forrás

Vizsgálati helyszínek

• Centre de Lutte contre le Cancer - Centre Oscar Lambret2 vizsgálat
• Centre de Lutte Contre le Cancer (CLCC) - Centre Oscar Lambret0 vizsgálat
• Centre Oscar Lambret320 vizsgálat
• Centre Oscar Lambret - cancerologie generale1 vizsgálat
• Centre Oscar Lambret, CLCC UNICANCER1 vizsgálat
• Centre Oscar Lambret, Department de Cancérologie Sénologique1 vizsgálat
• Centre Oscar Lambret /ID# 2706020 vizsgálat
• Centre Oscar Lambret /ID# 2721831 vizsgálat
• Centre Oscar Lambret, Lille4 vizsgálat
• Centre Oscar Lambret - Oncologie pédiatrie0 vizsgálat
• Centre Oscar Lambret - service de cancerologie gynecologique0 vizsgálat
• Centre Oscar Lambret - Service d'Oncologie medicale1 vizsgálat
• Centre Oscar Lambret - Service Oncologie2 vizsgálat
• Centre Oscar Lambret (Site 0401)1 vizsgálat
• Centre Oscar Lambret (Site 0495)0 vizsgálat
• Centre Oscar Lambret (Site 0634)0 vizsgálat
• Centre Oscar Lambret (Site # 0804)0 vizsgálat
• Centre Oscar Lambret (Site 0911)0 vizsgálat
• Centre Oscar Lambret (Site 0921)0 vizsgálat
• Centre Oscar Lambret (Site 1003)1 vizsgálat
• Centre Oscar Lambret (Site 1104)0 vizsgálat
• Centre Oscar Lambret (Site 1106)0 vizsgálat
• Centre Oscar Lambret (Site 1206)0 vizsgálat
• Centre Oscar Lambret (Site 2007)0 vizsgálat
• Centre Oscar Lambret - Unité d'onco-pédiatrie0 vizsgálat
• CTR Oscar Lambret1 vizsgálat
• Département de Cancérologie Urologique et Digestive, Centre Oscar Lambret1 vizsgálat
• Lille - Centre Oscar Lambret1 vizsgálat
• Oscar Lambret Center1 vizsgálat
• Privé - Cac - Centre Oscar Lambret0 vizsgálat
• Service de Chirurgie Digestive, Centre Oscar Lambret - Lille1 vizsgálat
• UNICANCER - Centre Oscar Lambret0 vizsgálat
• Centre Oscar Lambret0 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Prosztatarák49 munka · 33 vizsgálat
• Áttétes emlőrák23 munka · 48 vizsgálat